Screening for chlamydia trachomatis infection using the BDProbeTec™ ET Chlamydia trachomatis amplified DNA assay on urine in a GUM clinic setting: A simple, fast and cost-effective alternative

International Journal of STD and AIDS

Volumn 12, Issue 7, 2001, Pages 430-436

  Browning, M R ^a   Corden, S ^b   Mitchell, B ^b   Westmoreland, D ^b  

^a Cardiff Royal Infirmary   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

BDProbeTec ET assay; Chlamydia trachomatis; Culture; Nucleic acid amplification technology; Urine

Indexed keywords

ARTICLE; BACTERIUM DETECTION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DNA DETERMINATION; FEMALE; HOSPITAL DEPARTMENT; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; SCREENING TEST; UNITED KINGDOM; URINE CULTURE;

CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COST ALLOCATION; COST-BENEFIT ANALYSIS; DNA, BACTERIAL; FEMALE; FEMALE UROGENITAL DISEASES; HUMANS; MALE; MALE UROGENITAL DISEASES; NUCLEIC ACID AMPLIFICATION TECHNIQUES; OUTPATIENT CLINICS, HOSPITAL; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; WALES;

EID: 0034938642     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462011923453     Document Type: Article

References (27)

1. New cases seen in genitourinary clinics in England: 1998
2. Chlamydia trachomatis infections of the adult
3. Chlamydia trachomatis sexually transmitted disease
4. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection
5. Health gains from screening of the lower genital tract in women attending for termination of pregnancy
6. Early- and lateonset pelvic inflammatory disease among women with cervical Chlamydia trachomatis infection at the time of induced abortion - A follow-up study
7. Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: Ecological analysis
8. Is screening for Chlamydia trachomatis infection cost effective?
9. Chlamydia screening: Which sample for which technique?
10. Current methods of laboratory diagnosis of Chlamydia trachomatis infections
11. New methods in diagnostic and epidemiological research of Chlamydia trachomatis infections: The tide is turning molecular
12. The role of polymerase chain reaction and ligase chain reaction for the detection of Chlamydia trachomatis
13. Sensitivity of ligase chain reaction assay of urine from pregnant women for Chlamydia trachomatis
14. Diagnosis of Chlamydia trachomatis urethral infection in symptomatic and asymptomatic men by testing first-void urine in a ligase chain reaction assay
15. Detection of Chlamydia trachomatis antigens in urine as an alternative to swabs and cultures
16. Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine
17. Detection of Chlamydia trachomatis in genital swabs: Comparison of commercial and in house amplification methods with culture
18. Comparison of cervical, urethral and urine specimens for the detection of Chlamydia trachomatis in women
19. Strand displacement amplification and homogeneous real-time detection incorporated in a second-generation DNA probe system, BDProbeTec™ET
20. Pelvic inflammatory disease epidemiology: What do we know and what do we need to know?
21. National guideline for the management of Chlamydia trachomatis genital tract infection
22. Urethritis in women attending an STD clinic
23. Chlamydia trachomatis in women: The more you look, the more you find
24. PCR testing of genital and urine specimens compared with culture for the diagnosis of chlamydial infection in men and women
25. Diagnostic tests and specimens used to screen for Chlamydia trachomatis in genitourinary medicine clinics in the United Kingdom